ANDREA WEST: Open Payments
NPI 1942997978 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 54 payments from 17 companies in 2025. Trend: 2023 $890 · 2024 $859 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $208 |
| ABBVIE INC. | 10 | $149 |
| Novo Nordisk Inc | 4 | $75 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 6 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Lilly USA, LLC | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Lundbeck LLC | 1 | $32 |
Products named: AIRSUPRA, UBRELVY, GEMTESA, VOQUEZNA, Ozempic, VRAYLAR, FARXIGA, MOUNJARO.
Industry payments across AR — which companies pay providers there.
